Washington [US], September 20 (ANI): The findings of a recent study provide a novel theory as to how tumour cells avoid destruction by the immune system.
Washington [US], September 14 (ANI): Tumour cells are infamous for their ability to evade the human immune system; they construct physical barriers, disguise themselves, and handcuff the immune system with molecular tricks.
Washington [US], September 2 (ANI): Researchers have published results that show encouraging therapeutic options for patients with blood cancer and multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two
Bonn [Germany], August 28 (ANI): The protective scent that tumour cells spray themselves with suppresses the immune system. It seems, however, that a medicine that has already been approved for other uses can render this weapon harmless.
Bonn [Germany], August 26 (ANI): The immune system is suppressed by the protective scent that many tumour cells spray themselves with. However, it appears that a medicine that has already been approved for other uses can render this weapon harmless. A study from the University of Bonn and th
Washington [US], July 28 (ANI): A new class of glioma medications takes advantage of tumours lacking the DNA repair enzyme MGMT; the medications cause the generation of cytotoxic DNA and kill tumour cells specifically without the risk of developing resistance, according to research.
Ann Arbor [Michigan], June 29 (ANI): Numerous cell types, including both malignant and benign cells, make up tumours. One distinctive feature of the condition that makes therapy exceedingly challenging is the particular intricacy of the cells found inside brain tumours. Despite the fact that
Philadelphia (Pennsylvania) [US], June 13 (ANI): According to a recent study by researchers from the Perelman School of Medicine at the University of Pennsylvania, a stress protein that is overactive in several types of tumour cells also has a key role in tumour-supporting cells called fibro
Washington [US], May 27 (ANI): According to the scientists at the University of Michigan Rogel Cancer Center, a small molecule has been identified that blocks a key pathway in brain tumours. But there was a problem: How to get the inhibitor through the bloodstream and into the brain to reach
Washington [US], May 15 (ANI): The findings of a seven-year research project suggest a new approach to treat one of the most common and devastating forms of brain cancer in adults, Glioblastoma Multiforme.